Duygu FINDIK, Mecit SÜERDEM, Salih MAÇİN, Burcu YORMAZ, Hatice TÜRKDAĞI, Kazım KÖREZ

Short term results comparison of antibiotic resistance inCOPD patients with exacerbation

Aim: To obtain data which could be of guidance in the selection of empirical antibiotic treatment through bacteria isolation from sputum and antibiotic sensitivity tests in patients hospitalised because of exacerbation of chronic obstructive pulmonary disease (COPD).Materials and Methods: Sputum samples were induced before antibiotherapy in patients hospitalised because of COPD exacerbation. In addition to routine tests and infection markers, sputum cultures and antibiotic resistance tests were applied. Results: The study included 101 patients. Production was determined in the sputum cultures of 28 (27.7%) patients. In the group with bacteria isolated in the sputum, there was determined to be a high number of exacerbations in the last year, partial oxygen pressure (PaO2) was low, and procalcitonin (PCT), the neutrophil ratio, white blood cell count (WBC) and the modified Medical Research Council Dyspnea Score (mMRC) were found to be higher than in the patients with negative sputum (p

PDF

___

1. Singh D, Agusti A, Anzueto A , et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD sciencecommittee report 2019. Eur Respir J 2019;53:1900164.
2. Gruffydd-Jones K, Loveridge C. The 2010 NICE COPD Guidelines: how do they compare with the GOLD guidelines? Prim Care Respir J 2011;20:199.
3. Deniz S, Ozhan MH. Infective Exacerbations of Chronic Obstructive Pulmonary Disease with or without Pneumonia. Eurasian J Med 2014;16:31-5.
4. Ram FS, Rodriguez-Roisin R, Granados-Navarrete A,et al. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;2:CD004403.
5. Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173:1114-21.
6. Sapey E, Stockley RA. COPD exacerbations• 2: Aetiology. Thorax 2006;61:250-8.
7. American Thoracic Society. Standards for the diagnosis andcare of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:s77e120
8. Woods G, Washington J. The clinician and the microbiology laboratory. Principles and Practice of Infectious Diseases 4th ed Churchill Livingstone, New York. 1995.
9. Müller B, Prat C. Markers of acute inflammation in assessing and managing lower respiratory tract infections: focus on procalcitonin. Clin Microbiol Infect 2006;12:8-16.
10. Siddiqi A, Sethi S. Optimizing antibiotic selection in treating COPD exacerbations. Int J Chron Obstruct Pulmon Dis 2008;3:31.
11. ElFeky DS, Elmandory HM, Galal M et al. Sputum Bacteriology in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Int J Curr Microbiol App Sci 2016;5:289-305.
12. Patel A, Luhadia A, Luhadia S. Sputum bacteriology and antibiotic sensitivity pattern of patients having acute exacerbation of COPD in India: a preliminary study. J Pulm Respir Med 2015;5:2.
13. Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon? Proceedings of the American Thoracic Society 2004;1:109-14.
14. Barnes PJ, Drazen JM, Rennard SI et al.. Asthma and COPD: basic mechanisms and clinical management: Elsevier; 2009.
15. Mathew S, Zeitlin DS, Rickett K. Do antibiotics improve outcomes for patients hospitalized with COPD exacerbations? J Fam Pract 2012;61:561.
16. Stefan MS, Rothberg MB, Shieh M-S, et al.. Association between antibiotic treatment and outcomes in patients hospitalized with acute exacerbation of COPD treated with systemic steroids. Chest 2013;143:82-90.
17. Nagaraja C. Bacteriological profile and antibiotic sensitivity pattern in sputum culture of chronic obstructive pulmonary disease patients. Int J Advances in Med 2016;3:671.
18. Sharma P, Narula S, Sharma K, et al. . Sputum bacteriology and antibiotic sensitivity pattern in COPD exacerbation in India. Egyptian J Chest Diseases and Tuberculosis 2017;66:593-7.
19. Cals JW, Butler CC, Hopstaken RM, et al. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 2009;338:b1374.
20. Koutsokera A, Stolz D, Loukides S, et al. Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge. Chest 2012;141:396-405.
21. Mathioudakis AG, Chatzimavridou-Grigoriadou V, et al. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis. Eur Respir Rev 2017;26:160073.